Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Beer compound could help fend off Alzheimer's and Parkinson's diseases

  • Novel radioguided brain surgery technique could help pinpoint cancerous tissue

  • Concentrating on word sounds helps reading instruction and intervention

  • Molecular alterations in head and neck cancers uncovered by study

  • Why upper motor neurons degenerate in ALS

  • Cell imaging gets colorful

  • New theoretical framework for future studies of resilience

  • Playing with puzzles, blocks may build children's spatial skills

  • Intracranial stimulation proved efficient in the recovery of learning and memory in rats

  • New biological evidence reveals link between brain inflammation and major depression

  •